Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionPinnacle Associates Ltd
Latest Disclosed Ownership102,797 shares
Latest Disclosed Value $ 14,326,873
Pinnacle Associates Ltd reports 3.18% increase in ownership of GILD / Gilead Sciences, Inc.

On April 21, 2026 - Pinnacle Associates Ltd filed a 13F-HR form disclosing ownership of 102,797 shares of Gilead Sciences, Inc. (CH:GILD) valued at $14,326,873 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 99,628 shares of Gilead Sciences, Inc.. This represents a change in shares of 3.18% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-21 2026-03-31 13F GILEAD SCIENCES COM 375558103 102,797 3,169 3.18 14,327 17.16 0.1836
2026-02-05 2025-12-31 13F GILEAD SCIENCES COM 375558103 99,628 -3,713 -3.59 12,228 6.61 0.1569
2025-11-13 2025-09-30 13F GILEAD SCIENCES COM 375558103 103,341 1,525 1.50 11,471 1.61 0.1522
2025-08-04 2025-06-30 13F GILEAD SCIENCES COM 375558103 101,816 434 0.43 11,288 -0.63 0.1634
2025-05-06 2025-03-31 13F GILEAD SCIENCES COM 375558103 101,382 -1,167 -1.14 11,360 19.92 0.1665
2025-02-14 2024-12-31 13F GILEAD SCIENCES COM 375558103 102,549 42,735 71.45 9,472 95.50 0.1285
2024-10-25 2024-09-30 13F GILEAD SCIENCES COM 375558103 59,814 -39,331 -39.67 4,846 -28.77 0.0824
2024-07-30 2024-06-30 13F GILEAD SCIENCES COM 375558103 99,145 40,122 67.98 6,802 57.34 0.1065
2024-04-26 2024-03-31 13F GILEAD SCIENCES COM 375558103 59,023 -791 -1.32 4,323 -10.77 0.0681
2024-01-19 2023-12-31 13F GILEAD SCIENCES COM 375558103 59,814 1,033 1.76 4,846 9.99 0.0815
2023-10-24 2023-09-30 13F GILEAD SCIENCES COM 375558103 58,781 -3,701 -5.92 4,405 -8.52 0.0819
2023-07-27 2023-06-30 13F GILEAD SCIENCES COM 375558103 62,482 -2,384 -3.68 4,815 -10.52 0.0836
2023-05-05 2023-03-31 13F GILEAD SCIENCES COM 375558103 64,866 -3,274 -4.80 5,382 -8.00 0.1101
2023-02-01 2022-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 68,140 -1,815 -2.59 5,850 35.52 0.1275
2023-01-25 2022-12-31 13F GILEAD SCIENCES COM 375558103 69,495 -460 5,995 0.0001
2022-11-01 2022-09-30 13F GILEAD SCIENCES COM 375558103 69,955 -6,282 -8.24 4,316 -8.40 0.0991
2022-08-02 2022-06-30 13F GILEAD SCIENCES COM 375558103 76,237 -5,470 -6.69 4,712 -2.99 0.1027
2022-05-05 2022-03-31 13F GILEAD SCIENCES COM 375558103 81,707 -5,549 -6.36 4,857 -23.34 0.0860
2022-02-02 2021-12-31 13F GILEAD SCIENCES COM 375558103 87,256 -14,526 -14.27 6,336 -10.89 0.1093
2021-10-19 2021-09-30 13F GILEAD SCIENCES COM 375558103 101,782 -1,433 -1.39 7,110 0.04 0.1311
2021-08-02 2021-06-30 13F GILEAD SCIENCES COM 375558103 103,215 -15,861 -13.32 7,107 -7.65 0.1285
2021-05-12 2021-03-31 13F GILEAD SCIENCES COM 375558103 119,076 -4,734 -3.82 7,696 6.70 0.1468
2021-01-26 2020-12-31 13F GILEAD SCIENCES COM 375558103 123,810 -58,146 -31.96 7,213 -37.27 0.1465
2020-10-23 2020-09-30 13F GILEAD SCIENCES COM 375558103 181,956 -8,634 -4.53 11,498 -21.59 0.2731
2020-08-14 2020-06-30 13F GILEAD SCIENCES COM 375558103 190,590 -11,582 -5.73 14,664 -2.98 0.3616
2020-05-13 2020-03-31 13F GILEAD SCIENCES COM 375558103 202,172 2,594 1.30 15,114 16.54 0.4591
2020-02-03 2019-12-31 13F GILEAD SCIENCES COM 375558103 199,578 -25,780 -11.44 12,969 -9.20 0.2840
2019-11-08 2019-09-30 13F GILEAD SCIENCES COM 375558103 225,358 -1,881 -0.83 14,283 -6.96 0.3364
2019-08-05 2019-06-30 13F GILEAD SCIENCES COM 375558103 227,239 -2,771 -1.20 15,352 2.67 0.3595
2019-05-10 2019-03-31 13F GILEAD SCIENCES COM 375558103 230,010 4,813 2.14 14,953 6.16 0.3378
2019-02-05 2018-12-31 13F GILEAD SCIENCES COM 375558103 225,197 -39,549 -14.94 14,086 -31.09 0.3636
2018-11-09 2018-09-30 13F GILEAD SCIENCES COM 375558103 264,746 -12,674 -4.57 20,441 4.01 0.4241
2018-08-08 2018-06-30 13F GILEAD SCIENCES COM 375558103 277,420 -12,685 -4.37 19,652 -10.15 0.4043
2018-05-11 2018-03-31 13F GILEAD SCIENCES COM 375558103 290,105 -1,868 -0.64 21,871 4.56 0.4286
2018-02-12 2017-12-31 13F GILEAD SCIENCES COM 375558103 291,973 -8,609 -2.86 20,917 -14.11 0.4019
2017-11-13 2017-09-30 13F GILEAD SCIENCES COM 375558103 300,582 -2,067 -0.68 24,353 13.68 0.4490
2017-08-09 2017-06-30 13F GILEAD SCIENCES COM 375558103 302,649 8,926 3.04 21,422 7.38 0.4117
2017-05-09 2017-03-31 13F GILEAD SCIENCES COM 375558103 293,723 -6,082 -2.03 19,950 -7.08 0.3810
2017-02-10 2016-12-31 13F GILEAD SCIENCES COM 375558103 299,805 -16,768 -5.30 21,469 -14.29 0.4332
2016-11-14 2016-09-30 13F GILEAD SCIENCES COM 375558103 316,573 15,137 5.02 25,047 -0.39 0.5024
2016-08-15 2016-06-30 13F GILEAD SCIENCES COM 375558103 301,436 55,899 22.77 25,146 11.49 0.5419
2016-05-13 2016-03-31 13F GILEAD SCIENCES COM 375558103 245,537 8,989 3.80 22,555 -5.77 0.4825
2016-02-11 2015-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 236,548 4,399 1.89 23,936 5.01 0.5022
2016-02-09 2015-12-31 13F GILEAD SCIENCES COM 375558103 236,548 4,399 23,936 0.5115
2015-11-10 2015-09-30 13F GILEAD SCIENCES COM 375558103 232,149 21,617 10.27 22,795 -7.52 0.5044
2015-08-12 2015-06-30 13F GILEAD SCIENCES COM 375558103 210,532 -17,398 -7.63 24,649 10.20 0.4576
2015-05-15 2015-03-31 13F Gilead Sciences COM 375558103 227,930 -17,157 -7.00 22,367 -3.18 0.4173
2015-02-12 2014-12-31 13F Gilead Sciences COM 375558103 245,087 -9,839 -3.86 23,102 -14.87 0.4530
2014-11-12 2014-09-30 13F Gilead Sciences COM 375558103 254,926 -11,015 -4.14 27,137 23.08 0.5526
2014-08-14 2014-06-30 13F Gilead Sciences COM 375558103 265,941 -684 -0.26 22,049 16.70 0.4304
2014-05-14 2014-03-31 13F Gilead Sciences COM 375558103 266,625 -20,564 -7.16 18,893 -12.40 0.3684
2014-02-12 2013-12-31 13F Gilead Sciences COM 375558103 287,189 -3,718 -1.28 21,568 17.93 0.4211
2013-11-14 2013-09-30 13F Gilead Sciences COM 375558103 290,907 32,630 12.63 18,289 38.11 0.3784
2013-08-13 2013-06-30 13F Gilead Sciences COM 375558103 258,277 258,277 13,242 0.2976
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.